Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

7.77
+0.01000.13%
Pre-market: 8.100.3300+4.25%08:18 EDT
Volume:620.00K
Turnover:4.80M
Market Cap:401.03M
PE:-2.07
High:7.89
Open:7.75
Low:7.58
Close:7.76
52wk High:16.19
52wk Low:5.04
Shares:51.61M
Float Shares:43.00M
Volume Ratio:0.85
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7593
EPS(LYR):-3.7593
ROE:-107.00%
ROA:-21.93%
PB:3.90
PE(LYR):-2.07

Loading ...

Mar 13, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report